Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Harris

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The Journal of the American Osteopathic Association|February 22, 2013
Before the breaking point: reducing the risk of osteoporotic fractureDavid A Forstein, Catherine Bernardini, Raymond E Cole, et al.
Annals of the New York Academy of Sciences|December 7, 2007
Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonatesMone Zaidi, Solomon Epstein, Steven T Harris, et al.
Clinical Therapeutics|April 27, 2016
Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care PopulationAnkita Modi, Shiva Sajjan, E Michael Lewiecki, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Clinical use of teriparatide in the real world: initial insightsPaul D Miller, John P Bilezikian, Chad Deal, et al.
The Annals of Pharmacotherapy|March 26, 2009
Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronateWilliam A Blumentals, Steven T Harris, Raymond E Cole, et al.
Annals of Internal Medicine|November 23, 2006
Bisphosphonates and osteonecrosis of the jawNelson B Watts, Steven T Harris, Michael R McClung, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 24, 2004
Classification algorithms for hip fracture prediction based on recursive partitioning methodsHua Jin, Ying Lu, Steven T Harris, et al.
Mayo Clinic Proceedings|August 12, 2006
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databasesEthel S Siris, Steven T Harris, Clifford J Rosen, et al.
Postgraduate Medicine|May 31, 2022
The role of osteoanabolic agents in the management of patients with osteoporosisMichael R McClung, Micol S Rothman, E Michael Lewiecki, et al.
The American Journal of Medicine|June 2, 2019
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for OsteoporosisE Michael Lewiecki, David L Kendler, K Shawn Davison, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The Journal of the American Osteopathic Association|February 22, 2013
Before the breaking point: reducing the risk of osteoporotic fractureDavid A Forstein, Catherine Bernardini, Raymond E Cole, et al.
Annals of the New York Academy of Sciences|December 7, 2007
Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonatesMone Zaidi, Solomon Epstein, Steven T Harris, et al.
Clinical Therapeutics|April 27, 2016
Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care PopulationAnkita Modi, Shiva Sajjan, E Michael Lewiecki, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Clinical use of teriparatide in the real world: initial insightsPaul D Miller, John P Bilezikian, Chad Deal, et al.
The Annals of Pharmacotherapy|March 26, 2009
Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronateWilliam A Blumentals, Steven T Harris, Raymond E Cole, et al.
Annals of Internal Medicine|November 23, 2006
Bisphosphonates and osteonecrosis of the jawNelson B Watts, Steven T Harris, Michael R McClung, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 24, 2004
Classification algorithms for hip fracture prediction based on recursive partitioning methodsHua Jin, Ying Lu, Steven T Harris, et al.
Mayo Clinic Proceedings|August 12, 2006
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databasesEthel S Siris, Steven T Harris, Clifford J Rosen, et al.
Postgraduate Medicine|May 31, 2022
The role of osteoanabolic agents in the management of patients with osteoporosisMichael R McClung, Micol S Rothman, E Michael Lewiecki, et al.
The American Journal of Medicine|June 2, 2019
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for OsteoporosisE Michael Lewiecki, David L Kendler, K Shawn Davison, et al.
Pageof 4